Literature DB >> 10468126

AIDS-associated cryptococcal meningitis in Rwanda (1983-1992): epidemiologic and diagnostic features.

J Bogaerts1, D Rouvroy, H Taelman, A Kagame, M A Aziz, D Swinne, J Verhaegen.   

Abstract

OBJECTIVES: to document the trend of AIDS-associated Cryptococcus neoformans meningitis (CM) in Kigali, Rwanda, during 1983-1992, and to highlight some diagnostic and epidemiological features of the disease.
METHODS: during the study period, 3476 cerebrospinal fluid (CSF) specimens from 2824 adults (1578 men, 1246 women) were analysed in the Laboratory of Microbiology at the Centre Hospitalier de Kigali, Rwanda, Central Africa, using direct examination, culture and detection of the cryptococcal antigen (CrAg) in the CSF.
RESULTS: CM was diagnosed among 549 (19%) patients (347 men, 202 women) and was by far the leading cause of meningitis before Neisseria meningitidis (n=115), Streptococcus pneumoniae (n=68), Mycobacterium tuberculosis (n=26). E. coli, Klebsiella pneumoniae, non-typhoid Salmonella (n=l5) and streptococci (n=4). The number of CM increased from one case in 1983 to 130 new cases in 1992. All 293 tested CM patients had HIV-1 antibodies. The male/female ratio declined from 3.31 during 1983-1987 to 1.58 during 1988-1992. CM showed a seasonal fluctuation, the highest number of infections being observed during the long rainy season. The sensitivity and specificity of the latex test for diagnosing CM was 98% and 99%, respectively. Cryptococcus neoformans var. gattii was cultured from eight (1.6%) of the 499 culture positive patients.
CONCLUSION: CM is an important opportunistic infection among AIDS patients in Central Africa. It remains a problematic diagnosis in areas with limited diagnostic facilities.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10468126     DOI: 10.1016/s0163-4453(99)90099-3

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  20 in total

1.  Prevalence of cryptococcosis among HIV-infected patients in Yaounde, Cameroon.

Authors:  J P Dzoyem; F A Kechia; G P Ngaba; P K Lunga; P J Lohoue
Journal:  Afr Health Sci       Date:  2012-06       Impact factor: 0.927

2.  Transcription factor STE12alpha has distinct roles in morphogenesis, virulence, and ecological fitness of the primary pathogenic yeast Cryptococcus gattii.

Authors:  Ping Ren; Deborah J Springer; Melissa J Behr; William A Samsonoff; Sudha Chaturvedi; Vishnu Chaturvedi
Journal:  Eukaryot Cell       Date:  2006-07

3.  Most cases of cryptococcal meningitis in HIV-uninfected patients in Vietnam are due to a distinct amplified fragment length polymorphism-defined cluster of Cryptococcus neoformans var. grubii VN1.

Authors:  Jeremy N Day; Thu N Hoang; Anh V Duong; Chau T T Hong; Pham T Diep; James I Campbell; Tran P M Sieu; Tran T Hien; Tien Bui; Maciej F Boni; David G Lalloo; Dee Carter; Stephen Baker; Jeremy J Farrar
Journal:  J Clin Microbiol       Date:  2010-12-15       Impact factor: 5.948

4.  The prevalence, clinical features, risk factors and outcome associated with cryptococcal meningitis in HIV positive patients in Kenya.

Authors:  R Mdodo; K Brown; E Omonge; W Jaoko; J Baddley; P Pappas; M Colette Kempf; I Aban; S Odera; A Suleh; P E Jolly
Journal:  East Afr Med J       Date:  2010-12

5.  Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier.

Authors:  Yun C Chang; Monique F Stins; Michael J McCaffery; Georgina F Miller; Dan R Pare; Tapen Dam; Maneesh Paul-Satyaseela; Kwang Sik Kim; Kyung J Kwon-Chung; Maneesh Paul-Satyasee
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

6.  Evidence of sexual recombination among Cryptococcus neoformans serotype A isolates in sub-Saharan Africa.

Authors:  Anastasia P Litvintseva; Robert E Marra; Kirsten Nielsen; Joseph Heitman; Rytas Vilgalys; Thomas G Mitchell
Journal:  Eukaryot Cell       Date:  2003-12

Review 7.  Clinical and Microbiological Features of Salmonella Meningitis in a South African Population, 2003-2013.

Authors:  Karen H Keddy; Arvinda Sooka; Alfred Musekiwa; Anthony M Smith; Husna Ismail; Nomsa P Tau; Penny Crowther-Gibson; Frederick J Angulo; Keith P Klugman
Journal:  Clin Infect Dis       Date:  2015-11-01       Impact factor: 9.079

8.  Human immunodefeciency virus associated cryptococcal meningitis at a tertiary care centre: diagnostic tools and antifungal susceptibility testing.

Authors:  Rashmi Munivenkataswamy; Anjana Gopi; Shaik Mohammed Usman
Journal:  J Clin Diagn Res       Date:  2013-08-01

9.  Lymphocyte transformation assay for C neoformans antigen is not reliable for detecting cellular impairment in patients with neurocryptococcosis.

Authors:  Katya C Rocha; Cinthia Pinhal; Sônia Cavalcanti; Monica S M Vidal; Matheus Toscano; Dewton Moraes-Vasconcelos; Alberto J S Duarte; Fernando L A Fonseca; Luiz Carlos de Abreu; Vitor E Valenti; Anete S G Grumach
Journal:  BMC Infect Dis       Date:  2012-10-30       Impact factor: 3.090

10.  Comparison of biotyping methods as alternative identification tools to molecular typing of pathogenic Cryptococcus species in sub-Saharan Africa.

Authors:  Tinashe K Nyazika; Valerie J Robertson; Brenda Nherera; Prichard T Mapondera; Jacques F Meis; Ferry Hagen
Journal:  Mycoses       Date:  2015-12-10       Impact factor: 4.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.